Skip to main content

Postoperative Pain

31
Pipeline Programs
30
Companies
50
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
4
0
14
10
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
14100%
+ 50 programs with unclassified modality

Competitive Landscape

35 companies ranked by most advanced pipeline stage

Lundbeck
LundbeckDenmark - Copenhagen
4 programs
4
20 mL ropivacaine 5 mg/mLPhase 41 trial
EscitalopramPhase 41 trial
GabapentinPhase 41 trial
MethylprednisolonePhase 41 trial
Active Trials
NCT01012232Completed48Est. Oct 2009
NCT01430520Completed120Est. May 2013
NCT01507363Completed300Est. Nov 2013
+1 more trials
Purdue Pharma
Purdue PharmaCT - Stamford
3 programs
2
1
HydromorphonePhase 41 trial
Buprenorphine transdermal delivery systemPhase 21 trial
Buprenorphine transdermal patchPhase 21 trial
Active Trials
NCT00315835Completed100Est. Nov 1997
NCT00403234Terminated10Est. Aug 2007
NCT00465647Completed116Est. Apr 2010
Pfizer
PfizerNEW YORK, NY
2 programs
1
1
parecoxibPhase 4Small Molecule5 trials
IV DiclofenacPhase 31 trial
Active Trials
NCT00507026Completed277Est. Oct 2008
NCT00435747Withdrawn0
NCT01186159Completed90Est. Sep 2011
+3 more trials
Innovation Pharmaceuticals
2 programs
2
RopivacainePhase 41 trial
Ropivacaine 0.2%Phase 41 trial
Active Trials
NCT02829697Completed120Est. Mar 2017
NCT03372304Completed85Est. Feb 2019
Flow Medical
1 program
1
KetorolacPhase 41 trial
Active Trials
NCT00638508Completed67Est. Aug 2008
Defence Therapeutics
Defence TherapeuticsBC - Vancouver
1 program
1
Pregabalin 75mgPhase 41 trial
Active Trials
NCT06187922Unknown120Est. Jul 2025
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
5 programs
5
MK0966, rofecoxibPhase 3Small Molecule
MK0966, rofecoxibPhase 3Small Molecule
MK0966, rofecoxibPhase 3Small Molecule
MK0966, rofecoxibPhase 3Small Molecule
MK0966, rofecoxibPhase 3Small Molecule
MSD
MSDIreland - Ballydine
5 programs
5
MK0966, rofecoxibPhase 3Small Molecule1 trial
MK0966, rofecoxibPhase 3Small Molecule1 trial
MK0966, rofecoxibPhase 3Small Molecule1 trial
MK0966, rofecoxibPhase 3Small Molecule1 trial
MK0966, rofecoxibPhase 3Small Molecule1 trial
Active Trials
NCT00092313Completed271Est. Sep 2002
NCT00092339Completed125Est. Sep 2002
NCT00092326Completed269Est. Sep 2002
+2 more trials
Cumberland Pharmaceuticals
1 program
1
Intravenous IbuprofenPhase 3Small Molecule1 trial
Active Trials
NCT01297829Unknown51Est. Mar 2015
Paion
1 program
1
Morphine 6-glucuronidePhase 31 trial
Active Trials
NCT01082471Completed517Est. Dec 2006
Symbio Pharmaceuticals
1
SyB P-1501Phase 31 trial
Active Trials
NCT03005899Terminated49Est. Jul 2017
Medtronic
MedtronicNJ - Phillipsburg
1 program
1
MDT-10013Phase 21 trial
Active Trials
NCT02077140Completed192Est. Feb 2016
Sandoz
SandozAustria - Kundl
1 program
1
SAF312APhase 2
Sichuan Haisco Pharmaceutical
1 program
1
HSK21542Phase 11 trial
Active Trials
NCT04110886Completed120Est. Jan 2021
Baxter
BaxterCosta Rica - Cartago
1 program
1
ISBPhase 1
Chengdu Kanghong Pharmaceutical Group
1
KHN702Phase 11 trial
Active Trials
NCT07277933Not Yet Recruiting24Est. Feb 2026
Heron Therapeutics
10 programs
HTX-011PHASE_21 trial
HTX-011PHASE_21 trial
HTX-011PHASE_21 trial
HTX-011PHASE_21 trial
HTX-011PHASE_21 trial
+5 more programs
Active Trials
NCT03695367Completed63Est. Dec 2018
NCT03718039Completed78Est. Mar 2019
NCT02504580Completed463Est. Apr 2017
+7 more trials
Biocorp
2 programs
Continuous Wound InfusionN/A1 trial
PENG blockN/A1 trial
Active Trials
NCT05686382Unknown32Est. Dec 2023
NCT04306133Completed60Est. Dec 2020
City Therapeutics
City TherapeuticsMA - Cambridge
2 programs
Modifiye throcoabdominal nerve block through the perichondrial approachN/A1 trial
Sternotomy applicationN/A1 trial
Active Trials
NCT07403682Not Yet RecruitingEst. Sep 2026
NCT05357963UnknownEst. Aug 2024
Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
OxycodoneN/A1 trial
Personalizing Perioperative Analgesia in ChildrenN/A1 trial
Active Trials
NCT03495388Completed129Est. Jun 2022
NCT01140724Active Not Recruiting1,200Est. Dec 2026
SPR Therapeutics
Percutaneous peripheral nerve stimulationN/A1 trial
SPRINT Peripheral Nerve StimulationN/A1 trial
Active Trials
NCT02898103Completed7Est. Sep 2018
NCT04341948Completed56Est. Jun 2024
Merck & Co.
Merck & Co.RAHWAY, NJ
2 programs
MK0966, rofecoxibPHASE_3Small Molecule
MK0966, rofecoxibPHASE_3Small Molecule
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
Cold CompressionN/A1 trial
Active Trials
NCT00703729Completed58Est. Dec 2014
Verona Pharma
Verona PharmaUK - London
1 program
LOSN/A1 trial
Active Trials
NCT03685370Unknown154Est. Sep 2019
Pharmbio Korea
Pharmbio KoreaKorea - Seoul
1 program
Nefopam 80mg/dayN/A1 trial
Active Trials
NCT04450355Completed90Est. Nov 2021
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
POINTN/A1 trial
Active Trials
NCT04710069Completed102Est. Jan 2021
Providence Therapeutics
1 program
PandaN/A1 trial
Active Trials
NCT04139590Completed155Est. Aug 2016
Regenesis Biomedical
Regenesis BiomedicalAZ - Scottsdale
1 program
Provant Infinity Therapy SystemN/A1 trial
Active Trials
NCT04300907Withdrawn0Est. Mar 2020
Regenesis
RegenesisAZ - Scottsdale
1 program
Provant Infinity Therapy SystemN/A
United Therapeutics
United TherapeuticsMD - Silver Spring
1 program
SPRINT Peripheral Nerve StimulationN/A

+5 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Defence TherapeuticsPregabalin 75mg
Heron TherapeuticsHTX-011
Innovation PharmaceuticalsRopivacaine 0.2%
Innovation PharmaceuticalsRopivacaine
Teleflex MedicalBolus
LundbeckGabapentin
LundbeckEscitalopram
Pfizerparecoxib
Pfizerparecoxib
LundbeckMethylprednisolone
Lundbeck20 mL ropivacaine 5 mg/mL
Pfizerparecoxib
Flow MedicalKetorolac
Purdue PharmaHydromorphone
Heron TherapeuticsHTX-011

Showing 15 of 49 trials with date data

Clinical Trials (50)

Total enrollment: 9,868 patients across 50 trials

Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation

0
Phase 4Withdrawn

Effect of Perioperative Oral Pregabalin in Total Knee Replacement

Start: Sep 2023Est. completion: Jul 2025120 patients
Phase 4Unknown

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.

Start: Oct 2021Est. completion: Jul 202230 patients
Phase 4Completed

Catheter-based Peripheral Regional Anesthesia After Orthopedic Surgery to the Foot or Ankle

Start: Nov 2017Est. completion: Feb 201985 patients
Phase 4Completed

The Effect of Local Anaesthetic Volume on Nerve Block Duration and Nerve Block Duration Variability

Start: Jul 2016Est. completion: Mar 2017120 patients
Phase 4Completed

Continuous TAP Blocks: Relative Effects of a Basal Infusion vs. Repeated Bolus Doses

Start: Feb 2016Est. completion: Jun 201624 patients
Phase 4Completed

Analgesic Effect of Gabapentin in Total Knee Arthroplasty (TKA)

Start: Jan 2012Est. completion: Nov 2013300 patients
Phase 4Completed

Analgesic Effect of Escitalopram in Total Knee Arthroplasty (TKA)

Start: Sep 2011Est. completion: May 2013120 patients
Phase 4Completed

The Correlation of COX-2 Expression in Human Polymorphonuclear Leukocytes/Macrophages (PMNL/MP) and Postoperative Pain

Start: Nov 2010Est. completion: Sep 201190 patients
Phase 4Completed

Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative Pain

Start: Sep 2010Est. completion: Jun 2012900 patients
Phase 4Unknown
NCT00968578LundbeckMethylprednisolone

Effects of Methylprednisolone After Total Knee Arthroplasty

Start: Aug 2009Est. completion: Dec 200948 patients
Phase 4Completed
NCT01012232Lundbeck20 mL ropivacaine 5 mg/mL

Local Anesthetic in Total Knee Arthroplasty (TKA): Volume Versus Concentration

Start: Jun 2009Est. completion: Oct 200948 patients
Phase 4Completed

Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic

Start: Jun 2007Est. completion: Jun 2009340 patients
Phase 4Completed

ON-Q Pump Infusion of Ketorolac and Ropivacaine at the Wound Site for Postoperative Pain Management

Start: Jun 2007Est. completion: Aug 200867 patients
Phase 4Completed

An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain

Start: Apr 2007Est. completion: Apr 2010116 patients
Phase 4Completed

Bunionectomy Study for Postoperative Analgesia (EPOCH 1)

Start: Oct 2017Est. completion: Mar 2018412 patients
Phase 3Completed

Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)

Start: Jul 2017Est. completion: Jan 2018418 patients
Phase 3Completed

Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative Pain

Start: Nov 2016Est. completion: Jul 201749 patients
Phase 3Terminated

Does Preoperative Caldolor Decrease the Requirement for Postoperative Narcotics

Start: Feb 2011Est. completion: Mar 201551 patients
Phase 3Unknown
NCT00507026PfizerIV Diclofenac

Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery

Start: Jul 2007Est. completion: Oct 2008277 patients
Phase 3Completed
NCT01082471PaionMorphine 6-glucuronide

An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours

Start: Nov 2005Est. completion: Dec 2006517 patients
Phase 3Completed
NCT00092378MSDMK0966, rofecoxib

A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)

Start: Sep 2003Est. completion: Dec 2003251 patients
Phase 3Completed

Parecoxib In Post Surgery (Hemicolectomy) Pain

Start: Sep 2002Est. completion: Jan 200560 patients
Phase 3Terminated
NCT00092339MSDMK0966, rofecoxib

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)

Start: Aug 2002Est. completion: Sep 2002125 patients
Phase 3Completed
NCT00092313MSDMK0966, rofecoxib

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)

Start: Jun 2002Est. completion: Sep 2002271 patients
Phase 3Completed
NCT00092326MSDMK0966, rofecoxib

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)

Start: Jun 2002Est. completion: Sep 2002269 patients
Phase 3Completed
NCT00092300MSDMK0966, rofecoxib

A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)

Start: May 2002450 patients
Phase 3Completed

Parecoxib in Renal Colic

Start: Apr 2002Est. completion: Apr 200450 patients
Phase 3Terminated

Phase 2 Bunionectomy HTX-011 Administration Study

Start: Oct 2018Est. completion: Mar 201978 patients
Phase 2Completed

Phase 2 Herniorrhaphy Study for Opioid Elimination

Start: Oct 2018Est. completion: Dec 201863 patients
Phase 2Completed

Phase 2B Upper Extremity Nerve Block Study

Start: Jan 2017Est. completion: Mar 2018243 patients
Phase 2Completed

Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia

Start: Jan 2017Est. completion: May 2018285 patients
Phase 2Completed

Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

Start: May 2016Est. completion: Mar 2017430 patients
Phase 2Completed

Evaluation of the Efficacy and Safety of HTX-011 for Postoperative Analgesia Following Abdominoplasty Surgery

Start: Feb 2016Est. completion: Apr 2017277 patients
Phase 2Completed

Pilot Herniorrhaphy Study for Postoperative Analgesia

Start: Jul 2015Est. completion: Apr 2017463 patients
Phase 2Completed

A Study of MDT-10013 in the Treatment of Acute Postoperative Pain Following Bunionectomy

Start: Feb 2014Est. completion: Feb 2016192 patients
Phase 2Completed

To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients

Start: Sep 2009Est. completion: Mar 2011183 patients
Phase 2Completed
NCT00403234Purdue PharmaBuprenorphine transdermal patch

Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement

Start: Nov 2006Est. completion: Aug 200710 patients
Phase 2Terminated

A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy Surgery

Start: Aug 2002Est. completion: Feb 2003241 patients
Phase 2Completed
NCT00315835Purdue PharmaBuprenorphine transdermal delivery system

Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.

Start: Oct 1996Est. completion: Nov 1997100 patients
Phase 2Completed

Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects

Start: Dec 2025Est. completion: Feb 202624 patients
Phase 1Not Yet Recruiting

Safety, Tolerability, and Pharmacokinetics of HSK21542 in Healthy Volunteers

Start: Jul 2020Est. completion: Jan 2021120 patients
Phase 1Completed

Continuous Interscalene Block Results in Superior Recovery Throughout the First Postoperative Week

Start: Aug 2011Est. completion: Jun 201271 patients
Phase 1Completed
NCT07403682City TherapeuticsModifiye throcoabdominal nerve block through the perichondrial approach

M-TAPA vs ESPB for Postoperative Analgesia After Laparoscopic Cholecystectomy

Start: Mar 2026Est. completion: Sep 2026
N/ANot Yet Recruiting
NCT05686382BiocorpContinuous Wound Infusion

TAP Block vs CWI for Total Abdominal Hysterectomy, a RCT

Start: Jan 2023Est. completion: Dec 202332 patients
N/AUnknown
NCT05357963City TherapeuticsSternotomy application

Incidence of Chronic Pain After Sternotomy

Start: Apr 2022Est. completion: Aug 2024
N/AUnknown
NCT01140724Human BioSciencesPersonalizing Perioperative Analgesia in Children

Personalizing Perioperative Analgesia in Children

Start: Feb 2022Est. completion: Dec 20261,200 patients
N/AActive Not Recruiting
NCT04341948SPR TherapeuticsSPRINT Peripheral Nerve Stimulation

Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System

Start: Aug 2020Est. completion: Jun 202456 patients
N/ACompleted

Effects of Continuous Infusion of Intravenous Nefopam on Postoperative Pain and Opioid Consumption After VATS

Start: Jul 2020Est. completion: Nov 202190 patients
N/ACompleted

Postoperative Opt-In Narcotic Treatment Study

Start: Jun 2020Est. completion: Jan 2021102 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

14 late-stage (Phase 3) programs, potential near-term approvals
30 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.